Organization: MaRS Discovery District

CombiMatrix opens facility at MaRS

CombiMatrix Molecular Diagnostics (CMDX) is expanding its operations with the creation of a new facility at the MaRS Discovery District in Toronto. CMDX is the wholly owned subsidiary of CombiMatrix Group, one of two operating divisions of Acacia Research Corp, Newport Beach CA. It is developing a platform technology to rapidly produce customizable arrays —…

CombiMatrix opens facility at MaRS

CombiMatrix Molecular Diagnostics (CMDX) is expanding its operations with the creation of a new facility at the MaRS Discovery District in Toronto. CMDX is the wholly owned subsidiary of CombiMatrix Group, one of two operating divisions of Acacia Research Corp, Newport Beach CA. It is developing a platform technology to rapidly produce customizable arrays —…

Ontario government creates cancer research institute

The Ontario government is investing $142 million over four years to create the Ontario Institute for Cancer Research (OICR) with a core group of researchers located in the MaRS Discovery District. The OICR is being touted as the first collaborative research institute to focus on cancer from prevention through to treatment. The funding was announced…

New council will steer biotech policy in Ontario

Dale Patterson, executive VP of the Canadian Medical Discoveries Fund, will chair the steering committee of the Biotechnology Council of Ontario, a new organization that will advise the Ontario government on public policy issues facing the biotechnology industry. Administered by the MaRS Discovery District in Toronto, the council is open to all biotech stakeholders, and…